Rankings
▼
Calendar
CGEM Q1 2025 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CGEM
Cullinan Therapeutics, Inc.
$894M
Q1 2025 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$55M
Net Income
-$49M
EPS (Diluted)
$-0.82
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$43M
Free Cash Flow
-$43M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$580M
Total Liabilities
$28M
Stockholders' Equity
$552M
Cash & Equivalents
$77M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$76,000
+100.0%
Operating Income
-$55M
-$43M
-27.9%
Net Income
-$49M
-$37M
-30.6%
← FY 2025
All Quarters
Q2 2025 →